Baylor Scott & White Health: FDA-Approved Cellular Therapy for Metastatic Melanoma Now Available at Baylor University Medical Center in Dallas
February 22, 2024
February 22, 2024
DALLAS, Texas, Feb. 22 -- Baylor Scott and White Health issued the following news release:
After more than 18 months of working to meet the criteria to become an authorized treatment center, Baylor University Medical Center is poised to be one of the first in the nation to offer a newly FDA-approved tumor-infiltrating lymphocytes (TIL) cellular therapy treatment for patients with metastatic melanoma.
This novel therapy is now available to eligible patients. It is the fi . . .
After more than 18 months of working to meet the criteria to become an authorized treatment center, Baylor University Medical Center is poised to be one of the first in the nation to offer a newly FDA-approved tumor-infiltrating lymphocytes (TIL) cellular therapy treatment for patients with metastatic melanoma.
This novel therapy is now available to eligible patients. It is the fi . . .